SCHEDULE: Alexander Schornstein Discloses 6.53% MEI Pharma Stake
Beneficial Ownership Report
Alexander Schornstein has reported a 6.53% beneficial ownership stake in MEI Pharma, Inc., totaling 2,115,000 shares of common stock.
Summary
- Alexander Schornstein reported beneficial ownership of 2,115,000 shares of MEI Pharma, Inc. common stock.
- This ownership represents 6.53% of the company's outstanding common stock.
- The stake includes 1,890,000 shares held directly by Alexander Schornstein and 225,000 shares held by Camino Capital GmbH, where Mr. Schornstein is the sole beneficial owner.
- The percentage of class is based on 32,367,236 shares of common stock outstanding as stated in MEI Pharma, Inc.'s Form S-3 filing on August 6, 2025.
Sentiment
Score: 5
Explanation: This filing is a standard Schedule 13G reporting a passive ownership stake, which is generally neutral in sentiment as it does not indicate intent to influence control or provide operational updates.
Positives
- Disclosure of a significant 6.53% beneficial ownership stake by an individual investor, Alexander Schornstein, in MEI Pharma, Inc.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 08/06/2025 | Date of MEI Pharma, Inc.'s registration statement on Form S-3, which stated 32,367,236 shares of common stock outstanding. |
| 08/11/2025 | Date of event which required the filing of this statement. |
| 08/12/2025 | Date of filing of this Schedule 13G statement. |
Keywords
MEI Pharma, Alexander Schornstein, Common Stock, Beneficial Ownership, Schedule 13G, Shareholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.